CervoMed Inc —— 季度财务数据 (NASDAQ:CRVO) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -8.05 M-3.89 M-6.51 M-6.47 M-6.58 M -23.45 M 投资活动产生的现金 9.31 M5.4 M-254.99 K7.58 M5.37 M 18.1 M 融资活动产生的现金 0——00 — 自由现金流 -8.05 M-3.89 M-6.51 M-6.47 M-6.58 M -23.45 M

新闻

H.C. Wainwright重申CervoMed股票评级,基于会议数据

H.C. Wainwright reiterates CervoMed stock rating on conference data

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

CervoMed确定第三阶段痴呆症试验50毫克剂量

CervoMed sets 50mg dose for phase 3 dementia trial

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

CervoMed的neflamapimod入选英国ALS试验平台

CervoMed’s neflamapimod selected for UK ALS trial platform

Cantor Fitzgerald 给予 CervoMed 股票"增持"评级

Cantor Fitzgerald initiates CervoMed stock with Overweight rating

CervoMed股价在有前景的痴呆症药物试验结果后飙升